TL;DR
This study investigates the molecular mechanisms behind acupuncture's effectiveness in treating optic neuritis (ON), a common symptom of multiple sclerosis. Using an EAE mouse model and RNA sequencing, researchers found that needling at the GB20 acupoint can reverse gene expression changes associated with ON, particularly those involved in axon development and regeneration. The findings suggest a scientific basis for GB20 acupuncture in treating ocular diseases and highlight its potential impact on the retinal circadian rhythm.
What Problem Does This Paper Address?
Optic neuritis (ON) is a significant and often debilitating symptom of multiple sclerosis (MS), characterized by inflammation and damage to the optic nerve, leading to vision loss. While Traditional Chinese Medicine (TCM) practices, specifically needling at the GB20 acupoint, have shown clinical promise in treating ON and other ocular diseases, the underlying molecular mechanisms remain largely unknown. This lack of understanding hinders the integration of such therapies into mainstream medicine and limits the development of targeted treatments. This paper aims to bridge this knowledge gap by exploring how needling at GB20 influences gene expression in the retina of mice with ON.
Methods
The researchers employed a multi-faceted approach:
- Animal Model: They utilized the experimental autoimmune encephalomyelitis (EAE) mouse model, a standard model for studying demyelinating diseases like MS, to induce optic neuritis.
- Needling Intervention: Mice with EAE-induced ON were treated with needling at either the GB20 acupoint (experimental group) or the GV16 acupoint (control group) for two weeks. GV16 was chosen as a control due to its anatomical proximity to GB20 and its use in previous studies.
- RNA Sequencing (RNA-seq): This high-throughput technique was used to analyze the transcriptome of retinal tissue from different experimental groups (sham control, MOG-induced ON, GB20 needling, GV16 needling). RNA-seq allows for the identification and quantification of all RNA transcripts in a sample, providing a comprehensive view of gene expression.
- Bioinformatics Analysis:
- Differential Gene Expression Analysis: DESeq2 was used to identify genes whose expression levels significantly changed between groups. Genes with an adjusted p-value < 0.05 were considered differentially expressed.
- Gene Ontology (GO) Enrichment Analysis: This analysis was performed to understand the biological functions and pathways affected by ON and GB20 needling.
- KEGG Pathway Analysis: This was used to identify specific molecular pathways that were significantly altered.
Datasets
The study generated and analyzed RNA sequencing data from mouse retinal tissue. The raw data and GEO accession number for this study are available at: GSE148759, link: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE148759.
Key Insights and Ideas
- GB20 Needling Reverses ON-Induced Gene Changes: The most striking finding is that needling at GB20 can specifically reverse the expression of genes that were altered by ON. This suggests a direct therapeutic effect at the molecular level.
- Axon Development and Regeneration are Key Targets: Several genes reversed by GB20 needling, such as Nr4a3, Sncg, Uchl1, and Tppp3, are known to be involved in axon development and regeneration. Their downregulation by ON and subsequent reversal by GB20 treatment points to a mechanism that supports neuronal repair.
- Circadian Rhythm Regulation: A significant insight is the impact of GB20 needling on the circadian rhythm pathway in the retina. This is a novel finding, suggesting that acupuncture may influence biological clocks within the eye.
- GV16 as a Valid Control: The study reinforces the utility of GV16 as a control acupoint for GB20 in animal research, as most gene changes reversed by GV16 were also reversed by GB20, highlighting the specificity of GB20's effects.
Key Results
- ON Induces Significant Gene Expression Changes: In the EAE-induced ON model, 234 differentially expressed genes (DEGs) were identified in the retina, with 100 genes upregulated and 134 genes downregulated.
- GB20 Reverses Specific DEGs: Needling at GB20 specifically reversed the expression of 21 genes compared to the GV16 control group.
- Axon-Related Genes Show Beneficial Reversal: Among the reversed genes, Nr4a3, Sncg, Uchl1, and Tppp3 were downregulated by ON and subsequently upregulated by GB20 needling, indicating a positive effect on axon health.
- Circadian Rhythm Pathway Affected: GO enrichment analysis revealed that GB20 needling significantly impacted the molecular processes related to the circadian rhythm in the mouse retina.
Limitations and Future Work
- Clinical Score Unaffected: The study notes that needling treatment at either GB20 or GV16 did not affect the overall clinical score of EAE development in the mice. This suggests that while molecular changes occur, the macroscopic disease progression might not be directly altered by this specific intervention in this model.
- Mechanism of Action: While the study identifies affected genes and pathways, the precise molecular signaling cascade by which GB20 needling influences retinal gene expression remains unclear. The authors speculate that mechanical stimulation might activate neural pathways that feedback to the brain, influencing retinal gene expression.
- Future Directions: The authors suggest that further research is needed to elucidate the complex mechanisms involved. Investigating the role of nerve growth factors, brain-derived neurotrophic factors, and neural activity in mediating these effects would be valuable. Additionally, exploring the specific impact of GB20 on the retinal circadian rhythm and its potential therapeutic implications warrants further investigation.
Summary updated